5 Atrial Fibrillation Clinical Trials in Austin, MN (2026)

Q: How do I join a clinical trial in Austin?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Austin research site will contact you.

Recruiting Atrial Fibrillation Studies in Austin

NCT05759988Recruiting

Cervical Ripening as an Outpatient Method Using the Foley (COMFORT)

A multicenter pragmatic randomized trial of nulliparous women undergoing a term (≥37 weeks) induction of labor wherein the provider intends to use a Foley catheter for cervical ripening. The investiga...

Austin, MN2,300 participantsUniversity of Pennsylvania

View Study Details

NCT07575269Recruiting

Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation

The goal of this clinical trial is to learn if the FARAFLEX™ Mapping and pulsed field ablation (PFA) System can safely and effectively treat symptomatic, drug-refractory Paroxysmal atrial fibrillation...

Austin, MN571 participantsBoston Scientific Corporation

View Study Details

NCT07523750Recruiting

A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation

The purpose of this study is to assess how safe VARIPULSE pulsed field ablation (PFA) catheter is and how well it works compared to food and drug administration (FDA) approved FARAWAVE PFA catheter in...

Austin, MN466 participantsBiosense Webster, Inc.

View Study Details

NCT06099730Recruiting

Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF

The primary objective of this clinical investigation is to demonstrate the safety and 12-month effectiveness of pulmonary vein isolation (PVI) and posterior LA wall isolation in the treatment of subje...

Austin, MN442 participantsMassachusetts General Hospital

View Study Details

NCT06173778Recruiting

Semaglutide for Post-Smoking Cessation Weight Management

This trial will examine the effect of semaglutide 2.4mg on changes in body weight, body composition, and peripheral and central mechanisms that control appetite, satiety, and food intake in the contex...

Austin, MN197 participantsThe University of Texas Health Science Center, Houston

View Study Details

About Atrial Fibrillation Clinical Trials in Austin

Atrial fibrillation (AFib) is the most common type of heart arrhythmia, causing an irregular and often rapid heartbeat. It significantly increases the risk of stroke, heart failure, and other complications. Treatment includes blood thinners, heart rate or rhythm control medications, and procedures like ablation.

There are currently 5 atrial fibrillation clinical trials recruiting participants in Austin, MN. These studies are seeking a combined 3,976 participants. Research is being sponsored by University of Pennsylvania, Boston Scientific Corporation, Biosense Webster, Inc. and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atrial Fibrillation Clinical Trials in Austin — FAQ

Are there atrial fibrillation clinical trials in Austin?

Yes, there are 5 atrial fibrillation clinical trials currently recruiting in Austin, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Austin?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Austin research site will contact you about next steps.

Are clinical trials in Austin free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Austin studies also compensate for your time and travel.

What atrial fibrillation treatments are being tested?

The 5 active trials in Austin are testing new therapies including novel drugs, biologics, and treatment approaches for atrial fibrillation.

Data updated July 13, 2026 from ClinicalTrials.gov